Drugs with this side effect as MedDRA Preferred Term
- 4-PBA
- 5-ASA
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- A77 1726
- ALX 111
- APAs
- Anidulafungin
- BPTI
- Bivalirudin
- Urinary tract disorder: postmarketing
- Buscopan
- CGP 19835A
- Cancidas
- Urinary tract disorder: postmarketing
- Colimycin M
- D-penicillamine
- Enfuvirtide
- FK463
- Urinary tract disorder: postmarketing, 7.14% - 37.2%
- Forteo
- Gd-DTPA
- Glat copolymer
- Goserelin
- Urinary tract disorder: 1.28% - 3.18%
- Histrelin
- Urinary tract disorder: 4.7%
- Implanon
- Urinary tract disorder: postmarketing
- K779
- Urinary tract disorder: postmarketing, 5%
- LY146032
- Urinary tract disorder: postmarketing, uncommon, 15% - 22.4%
- Lisinopril
- Urinary tract disorder: postmarketing
- MDV3100
- Madopar
- Mersyndol
- NuvaRing
- PGE1
- Photofrin II
- Revasc
- SU5416
- Stalevo 50
- Triptorelin
- UDCA
- VACV
- Urinary tract disorder: very rare, postmarketing
- abiraterone
- acetaminophen
- Urinary tract disorder: postmarketing, rare
- aclidinium bromide
- acyclovir
- adefovir
- Urinary tract disorder: postmarketing
- adefovir dipivoxil
- Urinary tract disorder: postmarketing
- afatinib
- albendazole
- Urinary tract disorder: postmarketing
- alfuzosin
- aliskiren
- allopurinol
- alprazolam
- Urinary tract disorder: infrequent
- alvimopan
- amantadine
- ambrisentan
- amlodipine
- amlodipine besylate
- amoxicillin
- amphetamine
- amphotericin B
- amsacrine
- anagrelide
- Urinary tract disorder: 1-5%
- apixaban
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- atazanavir
- Urinary tract disorder: rare
- atomoxetine
- atovaquone
- avanafil
- axitinib
- baclofen
- betaine
- bexarotene
- bezafibrate
- bicalutamide
- boceprevir
- bortezomib
- bosentan
- bosutinib
- brinzolamide
- budesonide
- buprenorphine
- bupropion
- Urinary tract disorder: postmarketing
- busulfan
- cabazitaxel
- cabozantinib
- canagliflozin
- candesartan
- candesartan cilexetil
- Urinary tract disorder: postmarketing
- capecitabine
- carbamazepine
- carvedilol
- Urinary tract disorder: postmarketing
- cefaclor
- cefoxitin
- ceftaroline
- cefuroxime
- celecoxib
- cephalexin
- cetirizine
- Urinary tract disorder: very rare, postmarketing
- cevimeline
- cidofovir
- Urinary tract disorder: postmarketing
- cilazapril
- Urinary tract disorder: postmarketing
- ciprofloxacin
- cisplatin
- citalopram
- Urinary tract disorder: postmarketing, rare
- cladribine
- clarithromycin
- Urinary tract disorder: postmarketing, 0.273% - 0.578%
- clodronate
- clofarabine
- clomipramine
- Urethral disorder: infrequent
- Urinary tract disorder
- clonazepam
- clopidogrel
- Urinary tract disorder: postmarketing
- clozapine
- cobicistat
- codeine
- conivaptan
- copolymer 1
- crizotinib
- Urinary tract disorder: 0% - 4.07%
- cysteamine
- cytarabine
- d-telaprevir
- Urinary tract disorder: postmarketing
- dabigatran etexilate
- dabrafenib
- dalteparin
- dapagliflozin
- darifenacin
- Urinary tract disorder: uncommon
- darunavir
- dasatinib
- deferasirox
- Urinary tract disorder: postmarketing
- deferiprone
- deferoxamine
- degarelix
- delamanid
- deprenyl
- desmopressin
- desvenlafaxine
- diazepam
- diclofenac
- dihydrocodeine
- diltiazem
- docetaxel
- dolutegravir
- donepezil
- doxepin
- doxorubicin
- Urinary tract disorder: postmarketing
- duloxetine
- Urinary tract disorder: postmarketing
- efavirenz
- eletriptan
- Urinary tract disorder: infrequent
- empagliflozin
- emtricitabine
- entacapone
- eplerenone
- eribulin
- erlotinib
- ertapenem
- eslicarbazepine acetate
- esmolol
- estradiol
- Urethral disorder: postmarketing
- Urinary tract disorder
- ethosuximide
- etoposide
- etoricoxib
- Urinary tract disorder: postmarketing
- etravirine
- everolimus
- exenatide
- Urinary tract disorder: postmarketing
- febuxostat
- Urinary tract disorder: postmarketing
- fentanyl
- Urinary tract disorder: postmarketing, 1% - 3%
- fesoterodine
- flucloxacillin
- fluconazole
- fluvoxamine
- formoterol
- fosamprenavir
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fotemustine
- frovatriptan
- furosemide
- gabapentin
- gadobenate dimeglumine
- gadodiamide
- Urinary tract disorder: postmarketing
- gadofosveset
- gadoversetamide
- galantamine
- Urinary tract disorder: rare, infrequent
- ganciclovir
- gefitinib
- Urinary tract disorder: common, 12.8%
- gemcitabine
- gemifloxacin
- Urinary tract disorder: postmarketing
- glutamine
- Urinary tract disorder: 0% - 22.2%
- glycopyrrolate
- haloperidol
- Urinary tract disorder: postmarketing
- hydromorphone
- hydroxocobalamin
- hydroxybutyrate
- ibandronate
- ibuprofen
- idarubicin
- ifosfamide
- Urinary tract disorder: postmarketing
- iloperidone
- imatinib
- imipramine
- imiquimod
- Urinary tract disorder: postmarketing
- indapamide
- indinavir
- insulin detemir
- iodixanol
- Urinary tract disorder: very rare
- iohexol
- Urinary tract disorder: rare
- iopromide
- Urinary tract disorder: postmarketing
- iotrolan
- ipratropium bromide
- irbesartan
- Urinary tract disorder: postmarketing
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole
- Urinary tract disorder: postmarketing
- ixabepilone
- ketorolac tromethamine
- Urinary tract disorder: postmarketing
- lanreotide
- lansoprazole
- Urinary tract disorder: postmarketing
- lasofoxifene
- Urethral disorder: uncommon
- Urinary tract disorder: rare
- leflunomide
- lenalidomide
- Urinary tract disorder: postmarketing, 6.76%
- lercanidipine
- Urinary tract disorder: uncommon
- letrozole
- leuprorelin acetate
- Urinary tract disorder: very common
- levonorgestrel
- liraglutide
- Urinary tract disorder: postmarketing
- lomitapide
- loperamide
- Urinary tract disorder: postmarketing
- lormetazepam
- lurasidone
- mannitol
- maprotiline
- maraviroc
- medroxyprogesterone acetate
- mefenamic acid
- melatonin
- meloxicam
- Urinary tract disorder: postmarketing, 0% - 1.3%
- melphalan
- memantine
- Urinary tract disorder: postmarketing
- methotrexate
- methylene blue
- methylphenidate
- midodrine
- milnacipran
- Urinary tract disorder: postmarketing
- mirabegron
- mirtazapine
- Urinary tract disorder: postmarketing
- mitotane
- modafinil
- Urinary tract disorder: postmarketing
- montelukast
- Urinary tract disorder: postmarketing
- morphine
- moxifloxacin
- Urinary tract disorder: postmarketing
- mycophenolate mofetil
- mycophenolic acid
- naproxen
- Urinary tract disorder: postmarketing
- nelarabine
- neostigmine
- Urinary tract disorder: postmarketing
- nifedipine
- nilotinib
- nilutamide
- ofloxacin
- Urinary tract disorder: postmarketing
- olanzapine
- olmesartan
- olsalazine
- Urinary tract disorder: postmarketing
- omeprazole
- Urinary tract disorder: postmarketing
- orlistat
- oxaliplatin
- oxybutynin
- Urinary tract disorder: postmarketing, 8.5%
- oxycodone
- oxymorphone
- paclitaxel
- paliperidone
- Urinary tract disorder: postmarketing
- palonosetron
- pamidronate
- Urinary tract disorder: postmarketing
- pantoprazole
- Urinary tract disorder: postmarketing
- parecoxib
- paricalcitol
- pazopanib
- pemetrexed
- perindopril
- pioglitazone
- piperacillin
- pixantrone
- pomalidomide
- posaconazole
- Urinary tract disorder: 1.67% - 1.99%
- pramipexole
- prasugrel
- pregabalin
- Urinary tract disorder: postmarketing, infrequent
- progesterone
- propafenone
- Urinary tract disorder: postmarketing
- prucalopride
- Urinary tract disorder: common
- quetiapine
- Urinary tract disorder: 1%
- quinapril
- quinidine
- rabeprazole
- radium
- raloxifene
- Urinary tract disorder: 2.5%
- raltegravir
- Urinary tract disorder: uncommon
- ranolazine
- Urinary tract disorder: postmarketing
- rapamycin
- rasagiline
- reboxetine
- Urinary tract disorder: 7.83%
- regorafenib
- Urinary tract disorder: 33%
- retigabine
- retinoic acid
- ribavirin
- rifampicin
- rifapentine
- rifaximin
- rilpivirine
- riluzole
- Urinary tract disorder: 1%
- risedronate
- risperidone
- Urinary tract disorder: postmarketing, 16% - 43%
- ritonavir
- rivaroxaban
- rivastigmine
- Urethral disorder: infrequent
- Urinary tract disorder
- ropinirole
- Urethral disorder
- Urinary tract disorder
- ropivacaine
- rufinamide
- salbutamol
- salmon calcitonin acetate
- saquinavir
- scopolamine
- Urinary tract disorder: postmarketing
- sertraline
- Urinary tract disorder: postmarketing
- sevoflurane
- Urinary tract disorder: postmarketing
- sildenafil
- Urinary tract disorder: postmarketing
- sitagliptin
- Urinary tract disorder: postmarketing
- sitaxsentan
- solifenacin
- sorafenib
- Urinary tract disorder: postmarketing
- sufentanil
- sugammadex
- sulfasalazine
- Urinary tract disorder: postmarketing
- sunitinib
- Urinary tract disorder: postmarketing
- tacrolimus
- Urinary tract disorder: postmarketing
- tadalafil
- tapentadol
- teduglutide
- tegaserod
- telavancin
- telmisartan
- Urinary tract disorder: rare
- temozolomide
- temsirolimus
- tenofovir
- Urinary tract disorder: postmarketing
- tenofovir disoproxil fumarate
- Urinary tract disorder: postmarketing
- tenoxicam
- testosterone
- Urinary tract disorder: postmarketing
- testosterone enanthate
- Urinary tract disorder: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- thalidomide
- Urinary tract disorder: postmarketing
- thiotepa
- ticagrelor
- tinidazole
- tiotropium
- tipranavir
- tizanidine
- tobramycin
- tolcapone
- Urinary tract disorder: infrequent, common
- tolvaptan
- topiramate
- Urinary tract disorder: postmarketing, 0% - 4.1%
- tramadol
- Urinary tract disorder: postmarketing
- trametinib
- trandolapril
- travoprost
- trimethoprim
- trimethoprim-sulfamethoxazole
- trospium chloride
- v 1784
- Urinary tract disorder: postmarketing
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline
- vincristine
- Urinary tract disorder: 7.23%
- vinflunine
- voriconazole
- warfarin
- ziconotide
- Urinary tract disorder: uncommon
- zidovudine
- ziprasidone
- Urinary tract disorder: postmarketing
- zoledronic acid
- zolmitriptan
- Urinary tract disorder: rare
- zolpidem
- zonisamide
- zuclopenthixol
|